Skip to main content
. 2022 Jun 7;298(7):102104. doi: 10.1016/j.jbc.2022.102104

Table 2.

Effects of M4 C-terminal deletions on nAChR function and expression

Dose responsea
Deletion(s) EC50 (μM) pEC50 (M) Hill slope n
α subunit
 WT: …LAVFAGRLIELNQQG 7.61 5.12 ± 0.07 1.70 ± 0.47 50
 Δ1: …LAVFAGRLIELNQQ 6.86 5.17 ± 0.06 2.66 ± 0.67 9
 Δ2: …LAVFAGRLIELNQ 6.37 5.20 ± 0.07 2.62 ± 0.54 9
 Δ3: …LAVFAGRLIELN 7.14 5.15 ± 0.07 2.36 ± 0.38 8
 Δ4: …LAVFAGRLIEL 8.49 5.08 ± 0.07 2.13 ± 0.44 8
 Δ5: …LAVFAGRLIE 11.8 4.93 ± 0.04b 1.65 ± 0.33 10
 Δ6: …LAVFAGRLI 12.3 4.91 ± 0.04b 1.59 ± 0.25 10
 Δ7: …LAVFAGRL 12.7 4.90 ± 0.06b 1.54 ± 0.15 10
 Δ8: …LAVFAGR 14.7 4.84 ± 0.07b 1.46 ± 0.29 10
 Δ9: …LAVFAG 14.9 4.83 ± 0.08b 1.77 ± 0.35 10
 Δ10: …LAVFA 21.4 4.68 ± 0.08b 1.35 ± 0.12 10
 Δ11: …LAVF 23.0 4.65 ± 0.09b 1.69 ± 0.36 10
 Δ12: …LAV No currentc - - 8
β subunit
 WT: …LVIFLDATYHLPPPDPFP 7.61 5.12 ± 0.07 1.70 ± 0.47 50
 Δ1: …LVIFLDATYHLPPPDPF 9.77 5.02 ± 0.09 1.59 ± 0.08 13
 Δ2: …LVIFLDATYHLPPPDP 9.65 5.02 ± 0.05 1.61 ± 0.11 11
 Δ3: …LVIFLDATYHLPPPD 9.04 5.05 ± 0.08 1.46 ± 0.19 12
 Δ4: …LVIFLDATYHLPPP 7.00 5.13 ± 0.15 1.75 ± 0.13 10
 Δ8: …LVIFLDATYH 8.36 5.10 ± 0.16 1.79 ± 0.20 7
 Δ10: …LVIFLDAT 11.6 4.94 ± 0.08b 1.45 ± 0.21 9
 Δ13: …LVIFL 15.0 4.84 ± 0.14b 1.32 ± 0.30 11
 Δ15: …LVI 4.25 5.33 ± 0.15b 1.87 ± 0.20 9
δ subunit
 WT: …WIFLQGVYNQPPPQPFPGDPYSYNVQDKRFI 7.61 5.12 ± 0.07 1.70 ± 0.47 50
 Δ1: …WIFLQGVYNQPPPQPFPGDPYSYNVQDKRF 9.20 5.04 ± 0.07 1.46 ± 0.20 8
 Δ2: …WIFLQGVYNQPPPQPFPGDPYSYNVQDKR 7.72 5.13 ± 0.13 1.71 ± 0.13 8
 Δ3: …WIFLQGVYNQPPPQPFPGDPYSYNVQDK 5.95 5.24 ± 0.14 1.55 ± 0.10 8
 Δ4: …WIFLQGVYNQPPPQPFPGDPYSYNVQD 8.11 5.10 ± 0.07 1.60 ± 0.21 8
 Δ8: …WIFLQGVYNQPPPQPFPGDPYSY 8.88 5.06 ± 0.07 1.50 ± 0.33 9
 Δ12: …WIFLQGVYNQPPPQPFPGD 9.90 5.01 ± 0.06 1.32 ± 0.18 8
 Δ16: …WIFLQGVYNQPPPQP 14.2 4.85 ± 0.07b 1.68 ± 0.24 8
 Δ20: …WIFLQGVYNQP 15.1 4.84 ± 0.12b 1.51 ± 0.20 8
 Δ24: …WIFLQGV 7.59 5.12 ± 0.01 1.55 ± 0.13 3
 Δ28: …WIF No currentc 8
ε subunit
 WT: …SVGSSLIFLGAYFNRVPDLPYAPCIQP 7.61 5.12 ± 0.07 1.70 ± 0.47 50
 Δ1: …SVGSSLIFLGAYFNRVPDLPYAPCIQ 7.86 5.11 ± 0.05 1.62 ± 0.10 8
 Δ2: …SVGSSLIFLGAYFNRVPDLPYAPCI 6.40 5.20 ± 0.05 1.72 ± 0.08 8
 Δ3: …SVGSSLIFLGAYFNRVPDLPYAPC 8.44 5.08 ± 0.07 1.67 ± 0.11 9
 Δ4: …SVGSSLIFLGAYFNRVPDLPYAP 9.26 5.04 ± 0.06 1.47 ± 0.17 8
 Δ8: …SVGSSLIFLGAYFNRVPDL 6.20 5.22 ± 0.10 1.75 ± 0.25 8
 Δ13: …SVGSSLIFLGAYFN 3.47 5.46 ± 0.05b 1.87 ± 0.24 8
 Δ16: …SVGSSLIFLGA 4.22 5.38 ± 0.06b 1.87 ± 0.22 8
 Δ18: …SVGSSLIFL 1.89 5.74 ± 0.13b 1.99 ± 0.16 9
 Δ20: …SVGSSLI 1.21 5.92 ± 0.09b 1.87 ± 0.37 4
 Δ24: …SVG No currentc 8
a

Measurements performed 1 to 4 days after cRNA injection (Vhold ranging from −20 to −80 mV). Error values are represented as standard deviation.

b

p < 0.001 relative to WT via one-way ANOVA followed by Dunnet’s post hoc test.

c

No significant current observed up to 4 days after cRNA injection.